Sfoglia per AUTORE
ARAGONE MG
Collezione ASL Torino 4
Items : 2
Risankizumab shows faster response in bio naïve than in bio-experienced psoriatic patients. in Journal of the European Academy of Dermatology and Venereology : JEADV / J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e838-e841. doi: 10.1111/jdv.18314. Epub 2022 Jun 22.
2022
ASL Biella
ASL Asti
AOU Alessandria
ASL Alessandria
ASL Torino 4
ASL Biella
ASL Asti
AOU Alessandria
ASL Alessandria
ASL Torino 4
Passerini SG; Macagno N; Cariti C; Licciardello M; Solaroli C; Pertusi G; Aragone MG; Baggini G; Addese C; Leporati C; Peila R; Giura MT; Rossotto G; Pella P; Mocci L; Merlo G; Tiberio R; Graziola F; Quaglino P; Dapavo P; Ribero S; Ortoncelli M; Susca S; Boskovic S; Stroppiana E; Mastorino L; Verrone A; Castelli F;
Assessing the Beneficial Impact of a Patient Support Program in Secukinumab-Treated Patients with Psoriasis in Italy. in Patient preference and adherence / Patient Prefer Adherence. 2021 Nov 19;15:2551-2562. doi: 10.2147/PPA.S326498. eCollection 2021.
2021
ASL Alessandria
ASL Torino 4
ASL Alessandria
ASL Torino 4
Savoia P; Richetta AG; Peris K; Malara G; Loconsole F; Leporati C; Lembo S; Giofrè C; Foti C; Fargnoli MC; De Pasquale R; Costanzo A; Coppola S; Castelli G; Baggini G; Baldari M; Aragone MG; Amerio P; Argenziano G; Tiberio R; Travaglini M; Uzzauto MT; Bianchi L;